Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy.

Li C, Schwarz UI, Ritchie MD, Roden DM, Stein CM, Kurnik D
Blood. 2009 113 (17): 3925-30

PMID: 19074728 · PMCID: PMC2673121 · DOI:10.1182/blood-2008-09-176859

MeSH Terms (14)

Aryl Hydrocarbon Hydroxylases Cytochrome P-450 CYP2C9 Dose-Response Relationship, Drug Female Genotype Humans International Normalized Ratio Male Middle Aged Mixed Function Oxygenases Substrate Specificity Treatment Outcome Vitamin K Epoxide Reductases Warfarin

Connections (2)

This publication is referenced by other Labnodes entities: